▁St 10.375
. 3.916015625
▁J 6.07421875
ude 0.429443359375
▁Medical 4.25390625
▁Inc 3.080078125
' 6.515625
s 0.08917236328125
▁third 6.62890625
- 0.70849609375
qu 0.2410888671875
arter 0.005435943603515625
▁prof 4.6328125
its 0.026611328125
▁were 2.794921875
▁held 7.453125
▁back 0.80078125
▁due 3.83203125
▁to 0.0712890625
▁a 1.67578125
▁missed 7.234375
▁heart 7.046875
▁val 4.40234375
ve 0.001239776611328125
▁sale 3.634765625
▁to 2.740234375
▁Iran 10.3671875
▁and 2.306640625
▁other 3.82421875
▁factors 2.861328125
, 1.6162109375
▁the 1.4609375
▁company 2.021484375
▁reported 2.7578125
▁on 1.4228515625
▁T 1.74609375
ues 0.000911712646484375
day 0.052032470703125
. 0.1754150390625
<0x0A> 1.0166015625
Acc 5.52734375
ording 0.0219268798828125
▁to 0.01190948486328125
▁the 0.84228515625
▁report 2.1796875
, 0.16650390625
▁the 0.958984375
▁medical 3.3359375
▁technology 2.47265625
▁company 0.67041015625
' 1.75
s 0.0010328292846679688
▁re 2.5390625
venue 0.0018644332885742188
▁for 1.53515625
▁the 0.1019287109375
▁third 1.087890625
▁quarter 0.05352783203125
▁grew 4.13671875
▁only 6.1796875
▁ 0.433837890625
3 2.115234375
% 1.4130859375
▁to 1.1015625
▁$ 0.1748046875
1 1.1865234375
. 0.0980224609375
5 2.314453125
4 2.55859375
▁billion 0.13818359375
, 1.275390625
▁falling 4.8046875
▁short 0.382080078125
▁of 0.01512908935546875
▁anal 1.48828125
yst 0.000255584716796875
s 0.405029296875
' 0.06878662109375
▁expect 0.72119140625
ations 0.00024962425231933594
▁of 1.0283203125
▁$ 0.10845947265625
1 0.011383056640625
. 0.00577545166015625
5 0.421875
7 1.4912109375
▁billion 0.0458984375
. 0.1412353515625
▁The 2.29296875
▁company 0.81103515625
' 1.251953125
s 0.00024306774139404297
▁net 2.037109375
▁ear 2.701171875
nings 0.007793426513671875
▁for 1.4072265625
▁the 0.0275421142578125
▁quarter 0.6328125
▁were 1.3564453125
▁reported 5.0703125
▁to 2.693359375
▁be 0.2020263671875
▁$ 0.1890869140625
1 1.326171875
8 2.53125
6 2.4765625
▁million 0.45703125
, 0.346435546875
▁down 2.302734375
▁from 0.69921875
▁$ 0.21435546875
1 1.69921875
9 1.00390625
8 2.275390625
▁million 0.1116943359375
▁in 0.68310546875
▁the 0.1123046875
▁same 0.7197265625
▁period 0.94189453125
▁last 0.736328125
▁year 0.002742767333984375
. 0.1300048828125
<0x0A> 0.282470703125
St 1.8994140625
. 0.10284423828125
▁J 0.005725860595703125
ude 0.0003578662872314453
▁Medical 0.94873046875
▁attributed 5.859375
▁the 0.463134765625
▁we 3.99609375
aker 0.00095367431640625
- 0.7080078125
than 0.005214691162109375
- 0.00981903076171875
expected 0.0748291015625
▁performance 2.373046875
▁to 0.2176513671875
▁several 3.248046875
▁factors 0.1693115234375
, 0.395263671875
▁including 0.1614990234375
▁a 1.5224609375
▁missed 0.490234375
▁heart 1.1435546875
▁val 0.0129547119140625
ve 0.00034427642822265625
▁sale 0.1624755859375
▁to 0.071533203125
▁Iran 0.0673828125
▁due 4.4609375
▁to 0.00948333740234375
▁the 2.193359375
▁on 4.125
going 0.033843994140625
▁economic 4.0859375
▁san 0.2274169921875
ctions 0.0172119140625
▁against 2.3125
▁the 0.53271484375
▁country 0.36767578125
. 1.0068359375
▁The 0.91748046875
▁company 0.4521484375
▁estimated 6.41796875
▁that 0.6865234375
▁the 0.6611328125
▁lost 3.623046875
▁sale 1.5732421875
▁contributed 4.94921875
▁to 0.66796875
▁a 1.236328125
▁decl 3.607421875
ine 0.0035572052001953125
▁of 1.0947265625
▁about 2.11328125
▁ 0.85986328125
1 1.103515625
▁percentage 4.6484375
▁point 0.0113983154296875
▁in 0.533203125
▁its 1.2412109375
▁re 1.728515625
venue 0.0008630752563476562
▁growth 1.53515625
▁for 2.291015625
▁the 0.0280303955078125
▁quarter 0.406494140625
. 0.18017578125
<0x0A> 0.272216796875
In 2.673828125
▁addition 0.51611328125
▁to 2.01953125
▁the 0.47412109375
▁missed 1.6787109375
▁sale 1.197265625
, 0.460693359375
▁St 1.5087890625
. 0.003635406494140625
▁J 0.0023822784423828125
ude 0.00014340877532958984
▁Medical 0.26904296875
▁also 1.4912109375
▁experienced 2.619140625
▁slower 3.578125
- 1.3017578125
than 0.007007598876953125
- 0.00426483154296875
expected 0.22265625
▁sales 0.89111328125
▁growth 1.1279296875
▁in 0.60546875
▁its 1.03125
▁heart 3.583984375
▁rh 1.857421875
ythm 0.0010042190551757812
▁management 1.171875
▁division 2.28125
, 1.16796875
▁which 1.0791015625
▁includes 2.2734375
▁pac 3.21484375
em 0.0022735595703125
akers 0.024261474609375
▁and 0.41015625
▁impl 0.51611328125
ant 0.0100860595703125
able 0.0123748779296875
▁def 1.1416015625
ibr 0.002197265625
ill 2.9206275939941406e-05
ators 0.039398193359375
. 0.364990234375
▁The 0.8330078125
▁division 2.255859375
' 1.1748046875
s 0.00022470951080322266
▁re 1.0712890625
venue 0.0002079010009765625
▁grew 1.951171875
▁only 1.373046875
▁ 0.05096435546875
2 1.431640625
% 0.256591796875
▁to 1.0673828125
▁$ 0.0274658203125
7 2.513671875
5 2.267578125
4 2.3828125
▁million 0.033905029296875
, 1.0498046875
▁falling 2.583984375
▁short 0.08148193359375
▁of 0.0053253173828125
▁anal 0.75146484375
yst 4.124641418457031e-05
s 0.09637451171875
' 0.007167816162109375
▁expect 0.288330078125
ations 7.82012939453125e-05
▁of 0.07232666015625
▁$ 0.042999267578125
7 0.1695556640625
8 1.9794921875
7 2.57421875
▁million 0.115966796875
. 0.050140380859375
<0x0A> 0.265625
St 1.681640625
. 0.0287322998046875
▁J 0.0018720626831054688
ude 6.747245788574219e-05
▁Medical 0.086181640625
' 1.7490234375
s 0.0003345012664794922
▁card 3.8515625
i 1.8271484375
ov 0.66650390625
asc 0.00012755393981933594
ular 2.1696090698242188e-05
▁division 1.0498046875
, 1.0927734375
▁which 0.28662109375
▁includes 0.3310546875
▁its 1.396484375
▁heart 2.13671875
▁val 0.26708984375
ve 0.21240234375
▁products 1.8466796875
, 0.1417236328125
▁saw 1.6455078125
▁re 1.3115234375
venue 2.968311309814453e-05
▁growth 1.0732421875
▁of 0.0997314453125
▁ 0.250732421875
7 2.56640625
% 0.11767578125
▁to 0.126220703125
▁$ 0.0219879150390625
4 2.58984375
6 2.326171875
0 2.236328125
▁million 0.017578125
, 0.6240234375
▁but 3.541015625
▁still 3.109375
▁missed 1.2451171875
▁anal 0.297607421875
yst 5.507469177246094e-05
s 0.058563232421875
' 0.004848480224609375
▁expect 0.39453125
ations 2.8133392333984375e-05
▁of 0.10955810546875
▁$ 0.031768798828125
4 0.214599609375
8 1.4482421875
4 2.375
▁million 0.03228759765625
. 0.051422119140625
<0x0A> 0.52587890625
The 1.3330078125
▁company 0.4384765625
' 1.291015625
s 0.0004773139953613281
▁neur 6.5234375
om 0.0780029296875
od 0.01309967041015625
ulation 0.0009236335754394531
▁division 0.357666015625
, 0.591796875
▁which 0.06597900390625
▁includes 0.310546875
▁devices 4.9609375
▁for 1.69921875
▁tre 1.8115234375
ating 0.000133514404296875
▁chron 2.53515625
ic 0.0006093978881835938
▁pain 0.1446533203125
, 0.394287109375
▁saw 0.69384765625
▁re 0.299072265625
venue 2.9206275939941406e-05
▁growth 0.3896484375
▁of 0.024078369140625
▁ 0.1158447265625
6 2.783203125
% 0.144775390625
▁to 0.023590087890625
▁$ 0.007450103759765625
2 1.5009765625
4 2.3984375
9 2.42578125
▁million 0.0030765533447265625
, 0.436767578125
▁in 4.078125
▁line 0.091552734375
▁with 0.002559661865234375
▁anal 0.51123046875
yst 0.00010418891906738281
s 0.10028076171875
' 0.006969451904296875
▁expect 0.152587890625
ations 1.52587890625e-05
. 0.67578125
<0x0A> 0.171875
In 2.525390625
▁a 1.810546875
▁statement 0.80517578125
, 0.4462890625
▁St 0.5615234375
. 0.002620697021484375
▁J 0.001239776611328125
ude 6.508827209472656e-05
▁Medical 0.035491943359375
▁CE 1.3701171875
O 0.00011718273162841797
▁Dan 5.41796875
▁St 3.91796875
arks 4.6796875
▁acknowled 4.52734375
ged 0.00035858154296875
▁the 0.58740234375
▁challeng 1.791015625
es 0.25341796875
▁the 1.4189453125
▁company 0.139892578125
▁faced 0.474609375
▁in 0.85546875
▁the 0.2088623046875
▁third 0.499755859375
▁quarter 0.0232391357421875
, 0.9150390625
▁but 0.78564453125
▁emphas 3.841796875
ized 0.035400390625
▁the 1.5498046875
▁company 0.63330078125
' 0.32080078125
s 0.00035381317138671875
▁confidence 4.26171875
▁in 0.138916015625
▁its 0.424072265625
▁long 1.1513671875
- 0.00911712646484375
term 0.00836181640625
▁growth 1.0888671875
▁prospect 1.31640625
s 0.0038776397705078125
. 0.17041015625
<0x0A> 0.28173828125
" 0.1724853515625
Wh 2.322265625
ile 0.0015821456909179688
▁we 1.18359375
▁are 2.11328125
▁disappoint 0.251953125
ed 0.0002548694610595703
▁with 0.8720703125
▁our 0.6357421875
▁financial 3.140625
▁results 0.7255859375
▁this 2.630859375
▁quarter 0.04071044921875
, 0.0650634765625
▁we 0.363037109375
▁remain 1.2255859375
▁confident 0.45263671875
▁in 0.285888671875
▁our 0.436279296875
▁ability 1.763671875
▁to 0.007457733154296875
▁execute 2.529296875
▁our 2.107421875
▁strategy 1.1572265625
▁and 0.85546875
▁deliver 1.1064453125
▁long 1.0771484375
- 0.0201263427734375
term 0.00244140625
▁growth 1.06640625
," 1.0068359375
▁St 0.357666015625
arks 0.02081298828125
▁said 0.031524658203125
. 0.459716796875
▁" 0.513671875
We 0.80859375
▁continue 2.427734375
▁to 0.01433563232421875
▁make 2.13671875
▁significant 2.060546875
▁invest 0.880859375
ments 0.007274627685546875
▁in 0.379638671875
▁research 3.064453125
▁and 0.06976318359375
▁development 0.043548583984375
, 0.96240234375
▁clin 5.17578125
ical 0.01025390625
▁tri 1.001953125
als 3.516674041748047e-05
, 0.62548828125
▁and 0.81640625
▁commercial 2.38671875
ization 2.181640625
▁efforts 2.703125
▁to 0.97705078125
▁drive 2.203125
▁innov 2.54296875
ation 0.1033935546875
▁and 0.69384765625
▁growth 2.537109375
▁across 2.39453125
▁our 0.34326171875
▁port 1.6044921875
folio 0.00286865234375
▁of 1.138671875
▁ther 4.59375
ap 0.01702880859375
ies 4.267692565917969e-05
." 0.662109375
<0x0A> 0.08544921875
St 1.5185546875
. 0.2001953125
▁J 0.00246429443359375
ude 7.355213165283203e-05
▁Medical 0.08984375
▁also 3.09765625
▁announced 1.6796875
▁several 5.6796875
▁new 1.49609375
▁product 1.8427734375
▁launch 0.357177734375
es 0.01435089111328125
▁and 2.490234375
▁regul 4.46875
atory 0.00011563301086425781
▁appro 0.7138671875
val 0.00014209747314453125
s 0.01459503173828125
▁during 1.625
▁the 0.03546142578125
▁quarter 1.2060546875
, 1.0595703125
▁including 0.175048828125
▁the 0.88037109375
▁US 5.4140625
▁launch 4.53515625
▁of 0.044525146484375
▁its 0.7412109375
▁En 5.1484375
Site 1.083984375
▁X 2.4375
3 4.8125
▁mapping 5.29296875
▁system 0.484375
▁for 1.236328125
▁card 2.294921875
iac 0.08758544921875
▁ab 0.6904296875
lation 0.08447265625
▁procedures 0.69580078125
▁and 1.5322265625
▁the 0.6533203125
▁European 1.0068359375
▁appro 1.203125
val 0.00012981891632080078
▁of 0.10089111328125
▁its 0.52490234375
▁Ass 7.21875
urity 5.484375
▁M 4.5703125
RI 0.68505859375
▁pac 5.796875
em 0.072021484375
aker 0.102294921875
. 0.84033203125
<0x0A> 0.3134765625
Des 5.91015625
p 0.0179595947265625
ite 2.3603439331054688e-05
▁the 0.314453125
▁we 2.501953125
aker 3.5643577575683594e-05
- 0.1021728515625
than 0.0008349418640136719
- 0.0026874542236328125
expected 0.0251617431640625
▁performance 1.015625
▁in 1.150390625
▁the 0.08636474609375
▁third 0.241455078125
▁quarter 0.01113128662109375
, 0.044036865234375
▁some 7.1015625
▁anal 0.8310546875
yst 7.748603820800781e-05
s 0.0015707015991210938
▁remain 2.216796875
▁optim 0.74169921875
istic 0.0002167224884033203
▁about 0.19677734375
▁St 0.70458984375
. 0.0008535385131835938
▁J 0.000995635986328125
ude 0.00019049644470214844
▁Medical 0.1060791015625
' 0.135009765625
s 0.0002282857894897461
▁prospect 1.7255859375
s 0.0016927719116210938
. 0.626953125
▁In 3.4609375
▁a 0.2919921875
▁research 1.05859375
▁note 0.0928955078125
, 0.57421875
▁J 3.1796875
ef 0.58056640625
fer 8.52346420288086e-05
ies 0.0017271041870117188
▁& 5.0
▁Co 0.438232421875
▁anal 1.0068359375
yst 9.298324584960938e-06
▁Raj 7.0
▁Den 11.9921875
ho 0.7900390625
y 0.308349609375
▁noted 3.513671875
▁that 0.1339111328125
▁the 0.6943359375
▁company 0.21533203125
' 0.578125
s 0.00017189979553222656
▁card 2.919921875
i 0.50048828125
ov 0.150146484375
asc 0.0002009868621826172
ular 1.4066696166992188e-05
▁division 0.7314453125
▁" 3.02734375
cont 1.5234375
in 0.020263671875
ues 0.211669921875
▁to 0.01253509521484375
▁perform 2.50390625
▁well 0.42138671875
," 2.0546875
▁and 0.8896484375
▁that 1.3486328125
▁the 0.72900390625
▁company 0.69287109375
' 0.552734375
s 0.0002582073211669922
▁recent 3.80078125
▁product 2.208984375
▁launch 0.0872802734375
es 0.031463623046875
▁" 1.5576171875
should 2.1640625
▁help 1.791015625
▁support 3.5078125
▁growth 2.361328125
▁in 0.681640625
▁the 0.7685546875
▁coming 2.228515625
▁year 3.890625
." 0.0908203125
<0x0A> 0.1573486328125
Sh 4.765625
ares 0.07464599609375
▁of 0.09686279296875
▁St 0.0731201171875
. 0.0018939971923828125
▁J 0.0008950233459472656
ude 6.842613220214844e-05
▁Medical 0.01171112060546875
▁were 1.078125
▁down 1.0966796875
▁ 0.45458984375
2 1.751953125
. 0.31494140625
2 2.16796875
% 0.56298828125
▁in 0.65234375
▁pre 0.99951171875
market 0.356201171875
▁trad 0.292724609375
ing 4.0531158447265625e-05
▁on 0.734375
▁T 0.2144775390625
ues 1.4185905456542969e-05
day 7.224082946777344e-05
▁following 5.05078125
▁the 0.1055908203125
▁release 1.34765625
▁of 0.01242828369140625
▁the 0.51513671875
▁third 3.072265625
- 0.0906982421875
qu 0.0002491474151611328
arter 0.00014448165893554688
▁ear 0.72705078125
nings 0.0026416778564453125
▁report 0.37158203125
. 0.055267333984375
▁The 1.0908203125
▁company 1.140625
' 0.26416015625
s 9.85860824584961e-05
▁stock 0.51611328125
▁has 0.5009765625
▁fallen 2.158203125
▁about 1.939453125
▁ 0.0024127960205078125
1 1.0595703125
0 1.951171875
% 0.06549072265625
▁since 1.8330078125
▁the 0.29296875
▁beginning 0.51513671875
▁of 0.0006785392761230469
▁the 0.346923828125
▁year 0.02593994140625
. 0.5859375
